147 related articles for article (PubMed ID: 16098511)
1. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.
Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2005 Aug; 579(21):4719-23. PubMed ID: 16098511
[TBL] [Abstract][Full Text] [Related]
2. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress.
Dairou J; Malecaze F; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2005 Apr; 67(4):1299-306. PubMed ID: 15644493
[TBL] [Abstract][Full Text] [Related]
3. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
4. Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study.
Dairou J; Atmane N; Rodrigues-Lima F; Dupret JM
J Biol Chem; 2004 Feb; 279(9):7708-14. PubMed ID: 14672957
[TBL] [Abstract][Full Text] [Related]
5. Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants.
Dairou J; Petit E; Ragunathan N; Baeza-Squiban A; Marano F; Dupret JM; Rodrigues-Lima F
Toxicol Appl Pharmacol; 2009 May; 236(3):366-71. PubMed ID: 19248797
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of human arylamine N-acetyltransferase 1 by hydrogen peroxide and peroxynitrite.
Dupret JM; Dairou J; Atmane N; Rodrigues-Lima F
Methods Enzymol; 2005; 400():215-29. PubMed ID: 16399351
[TBL] [Abstract][Full Text] [Related]
7. Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity.
McQueen CA; Chau B
Toxicol Sci; 2003 Jun; 73(2):279-86. PubMed ID: 12700401
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscles express the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase.
Rodrigues-Lima F; Cooper RN; Goudeau B; Atmane N; Chamagne AM; Butler-Browne G; Sim E; Vicart P; Dupret JM
J Histochem Cytochem; 2003 Jun; 51(6):789-96. PubMed ID: 12754290
[TBL] [Abstract][Full Text] [Related]
9. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
Ragunathan N; Dairou J; Pluvinage B; Martins M; Petit E; Janel N; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2008 Jun; 73(6):1761-8. PubMed ID: 18310302
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
11. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
[TBL] [Abstract][Full Text] [Related]
12. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
[TBL] [Abstract][Full Text] [Related]
13. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
Wang H; Liu L; Hanna PE; Wagner CR
Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
[TBL] [Abstract][Full Text] [Related]
14. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases.
Dupret JM; Rodrigues-Lima F
Curr Med Chem; 2005; 12(3):311-8. PubMed ID: 15723621
[TBL] [Abstract][Full Text] [Related]
15. Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene.
Cornish VA; Pinter K; Boukouvala S; Johnson N; Labrousse C; Payton M; Priddle H; Smith AJ; Sim E
Pharmacogenomics J; 2003; 3(3):169-77. PubMed ID: 12815365
[TBL] [Abstract][Full Text] [Related]
16. The human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): mechanism and kinetics.
Ragunathan N; Busi F; Pluvinage B; Sanfins E; Dupret JM; Rodrigues-Lima F; Dairou J
FEBS Lett; 2010 Aug; 584(15):3366-9. PubMed ID: 20591428
[TBL] [Abstract][Full Text] [Related]
17. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
18. Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells.
Estrada-Rodgers L; Levy GN; Weber WW
Drug Metab Dispos; 1998 May; 26(5):502-5. PubMed ID: 9571233
[TBL] [Abstract][Full Text] [Related]
19. Developmental expression of N-acetyltransferases in C57BI/6 mice.
Mitchell MK; Futscher BW; McQueen CA
Drug Metab Dispos; 1999 Feb; 27(2):261-4. PubMed ID: 9929513
[TBL] [Abstract][Full Text] [Related]
20. Nitration of a critical tyrosine residue in the allosteric inhibitor site of muscle glycogen phosphorylase impairs its catalytic activity.
Dairou J; Pluvinage B; Noiran J; Petit E; Vinh J; Haddad I; Mary J; Dupret JM; Rodrigues-Lima F
J Mol Biol; 2007 Sep; 372(4):1009-1021. PubMed ID: 17689562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]